Journals / Turkish Journal of Medical Sciences / 2016 / Cilt: 46 - Sayı: 3

Investigating the in vitro synergistic activities of several antibiotic combinationsagainst carbapenem-resistant Acinetobacter baumannii isolates

Pages
892–896
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Among the tested antimicrobial combinations, the in vitro combination of MEM with TGC or CST was most effective against the CR A. baumannii strains.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/aim: Acinetobacter baumannii (A. baumannii) is one of the most common healthcare-associated infectious agents worldwide.
📊
Key Findings & Data:Materials and methods: Eighteen CR A. baumannii strains were isolated from the patients who were hospitalized in the intensive care unit between June 2012 and August 2012.
💡
Conclusion & Impact:Conclusion: Among the tested antimicrobial combinations, the in vitro combination of MEM with TGC or CST was most effective against the CR A. baumannii strains.
🔬Design:Research Article
📍Scope:2012 Verileri
⚙️Variables:Domain Parameters

Abstract

Background/aim: Acinetobacter baumannii (A. baumannii) is one of the most common healthcare-associated infectious agents worldwide. The aim of this study was to investigate the in vitro synergistic activities of several antibiotic combinations against carbapenem-resistant (CR) A. baumannii isolates. Materials and methods: Eighteen CR A. baumannii strains were isolated from the patients who were hospitalized in the intensive care unit between June 2012 and August 2012. The in vitro effects of single and binary combinations of meropenem (MEM), colistin (CST), tigecycline (TGC), and sulbactam (SUL) on these isolates were determined using the Epsilometer test (E-test) method. Results: All 18 isolates were resistant to MEM and SUL and susceptible to CST. TGC was detected as susceptible in two of the isolates and intermediate susceptibility results were observed in the remaining isolates. With MEM-CST and MEM-TGC combinations, synergism was determined against all isolates. The synergistic and/or additive effect ratios were detected in MEM-SUL, CST-SUL, TGC-SUL, and CST-TGC combinations as 16.7%, 38.9%, 16.7%, and 5.6%, respectively. Conclusion: Among the tested antimicrobial combinations, the in vitro combination of MEM with TGC or CST was most effective against the CR A. baumannii strains.

🔖

Cite This Article

BAŞTUĞ, A., AKINCI, E., BODUR, H., KANYILMAZ, D., KAYAASLAN, B., SARI, B., ASLANER, H., BUT, A., YAVAŞ, S., YETKİN, M. A. (2022). Investigating the in vitro synergistic activities of several antibiotic combinationsagainst carbapenem-resistant Acinetobacter baumannii isolates. Turkish Journal of Medical Sciences, Cilt: 46 - Sayı: 3, 892–896. https://ajindex.com/articles/610844

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Iacono M, Villa L, Fortini D, Bordoni R, Imperi F, Bonnal RJP, Sicheritz-Ponten T, Bellis G, Visca P, Cassone A, Carattoli A. Whole-genome pyrosequencing of an epidemic multidrugresistant Acinetobacter baumannii strain belonging to the european clone II group. Antimicrob Agents Ch 2008; 52: 2616-2625
  2. Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 2008; 21: 538-582
  3. Akalın H. The antibiotic treatment approach for multidrugresistance and antibiotic stewardship. ANKEM Derg 2007; 21: 186-191 (article in Turkish with an abstract in English)
  4. Ürkmez K, Şengöz G. The evaluation of amikacin and meropenem combination according to FIC index criteria with E-test method in resistant Pseudomonas strains (article in Turkish with an abstract in English). Klimik Journal 2005; 18: 45-47
  5. Balke B, Hogardt M, Schmoldt S, Hoy L, Weissbrodt H, Haussler S. Evaluation for the E-test for the assessment of synergy of antibiotic combinations against multiresistant Pseudomonas aeruginosa isolates from cyctic fibrosis patients. Eur J Clin Microbiol 2006; 25: 25-30
  6. Chachanidze V, Curbelo-Irizarry A, Ashcraft D, Pankey G. In vitro synergy of levofloxacin plus piperacillin/tazobactam against Pseudomonas aeruginosa. Interdiscip Perspect Infect Dis 2009; 2009: 984934
  7. Bal Ç. [Antibiyotik kombinasyonlarının in vitro etkinliğinin saptanması.]. FLORA 1999; 4: 219-229 (article in Turkish)
  8. The Clinical and Laboratory Standards Institute (CLSI). Zone diameter interpretive standards and equivalent minimal inhibitory concentration (MIC) breakpoints for Acinetobacter species (Table 2B-2). In: Performance Standards for Antimicrobial Susceptibility Testing; 17th Informational Supplement; M100-S17. Wayne, PA, USA: The Clinical and Laboratory Standards Institute (CLSI); 2007. pp. 40-41
  9. Henwood CJ, Gatward T, Warner M, Jamesa D, Stockdalea MW, Spenceb RP, Townerb KJ, Livermorea DM, Woodforda N. Antibiotic resistance among clinical isolates of Acinetobacter in the UK, and in vitro evaluation of tigecycline (GAR-936). J Antimicrob Chemoth 2002; 49: 479-487
  10. Liang-Yu C, Kuo SC, Liu CY, Luo BS, Huang LJ, Lee YT, Chen CP, Chen TL, Fung CP. Difference in imipenem, meropenem, sulbactam, and colistin nonsusceptibility trends among three phenotypically undifferentiated Acinetobacter baumannii complex in a medical center in Taiwan, 1997–2007. J Microbiol Immunol 2011; 44: 358-363
  11. Karageorgopoulos DE, Kelesi